Trial Profile
A Study to Evaluate the Effects of Fingolimod on Migration of T Cells Toward CNS Without Interfering with Their Anti-Viral Properties Versus Other Disease Modifying Treatments in Patients With Multiple Sclerosis (MS)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Feb 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary) ; Natalizumab
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 26 Feb 2016 New trial record